Back to today’s briefing

Story perspectives

Hims & Hers Shares Slip Despite Revenue Surge and Buyback

11/18/2025

34 5 Full Breakdown

Summary

Story summary

Hims & Hers Health shares fell 4.9% after Novo Nordisk cut GLP-1 prices.
The company announced a $250 million share repurchase to capitalize on undervaluation.
Despite a 49.2% revenue increase to $599 million, profit fell short of expectations.
Shares trade at $34.57, far below the 52-week high of $68.74.
Investors who bought five years ago would gain $3,406 on a $1,000 investment.

1 of 1

Story summary

Hims & Hers Health shares fell 4.9% after Novo Nordisk cut GLP-1 prices.
The company announced a $250 million share repurchase to capitalize on undervaluation.
Despite a 49.2% revenue increase to $599 million, profit fell short of expectations.
Shares trade at $34.57, far below the 52-week high of $68.74.
Investors who bought five years ago would gain $3,406 on a $1,000 investment.